{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:34:34Z","timestamp":1793162074185,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ijbiomac.2023.123318","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T13:10:05Z","timestamp":1674047405000},"page":"123318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Structure restoration and aggregate inhibition of V30M mutant transthyretin protein by potential quinoline molecules"],"prefix":"10.1016","volume":"231","author":[{"given":"Sachin","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay Kumar","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rituraj","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2023.123318_bb0005","doi-asserted-by":"crossref","first-page":"8928","DOI":"10.1021\/jm500997m","article-title":"Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin","volume":"57","author":"Yokoyama","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/TCRM.S219979","article-title":"Diagnosis and treatment of hereditary transthyretin amyloidosis (Hattr) polyneuropathy: current perspectives on improving patient care","volume":"16","author":"Luigetti","year":"2020","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0015","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1056\/NEJM199702133360703","article-title":"Variant-sequence transthyretin (Isoleucine 122) in late-onset cardiac amyloidosis in Black Americans","volume":"336","author":"Jacobson","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0020","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1432-1033.1997.00662.x","article-title":"Comparative stability and clearance of [Met30]transthyretin and [Met119]transthyretin","volume":"249","author":"Longo Alves","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0025","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s00415-017-8708-4","article-title":"Transthyretin familial amyloid polyneuropathy: an update","volume":"265","author":"Plante-Bordeneuve","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143456","article-title":"Amyloid cardiomyopathy in hereditary transthyretin V30M amyloidosis - impact of sex and amyloid fibril composition","volume":"10","author":"Arvidsson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0035","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1021\/acs.jmedchem.8b01700","article-title":"Crown ethers as transthyretin amyloidogenesis inhibitors","volume":"62","author":"Yokoyama","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0040","article-title":"Cavity filling mutations at the thyroxine-binding site dramatically increase transthyretin stability and prevent its aggregation","volume":"7","author":"Sant'Anna","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-27481-4","article-title":"Structural basis for transthyretin amyloid formation in vitreous body of the eye","volume":"12","author":"Iakovleva","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0050","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1006\/jmbi.2000.4415","article-title":"Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution","volume":"306","author":"Sebasti\u00e3o","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-019-1369-4","article-title":"Inflammatory profiling of patients with familial amyloid polyneuropathy","volume":"19","author":"Azevedo","year":"2019","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0060","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/gt.2014.86","article-title":"Gene therapy approach to FAP: in vivo influence of T119M in TTR deposition in a transgenic V30M mouse model","volume":"21","author":"Batista","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0065","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1126\/science.1062245","article-title":"Trans-suppression of misfolding in an amyloid disease","volume":"293","author":"Hammarstr\u00f6m","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0070","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1126\/science.1079589","article-title":"Prevention of transthyretin arnyloid disease by changing protein misfolding energetics","volume":"299","author":"Hammarstr\u00f6m","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0075","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1073\/pnas.1121005109","article-title":"Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade","volume":"109","author":"Bulawa","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0080","doi-asserted-by":"crossref","first-page":"14228","DOI":"10.1021\/acs.jmedchem.0c00934","article-title":"Transthyretin amyloidogenesis inhibitors: from discovery to current developments","volume":"63","author":"Yokoyama","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0085","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cardfail.2019.11.024","article-title":"Stabilization of cardiac function with diflunisal in transthyretin (ATTR) cardiac amyloidosis","volume":"26","author":"Lohrmann","year":"2020","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0090","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/ene.12225","article-title":"Effect on disability and safety of tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy","volume":"20","author":"Lozeron","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0095","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/07853890.2015.1068949","article-title":"Evolving landscape in the management of transthyretin amyloidosis","volume":"47","author":"Hawkins","year":"2015","journal-title":"Ann. Med."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0100","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ejmech.2016.08.003","article-title":"Systemic optimization and structural evaluation of quinoline derivatives as transthyretin amyloidogenesis inhibitors","volume":"123","author":"Kim","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0105","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.1039\/c3cc44667k","article-title":"Bifunctional coumarin derivatives that inhibit transthyretin amyloidogenesis and serve as fluorescent transthyretin folding sensors","volume":"49","author":"Myung","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0110","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2174\/1573406414666181015144413","article-title":"Evaluation of antiplasmodial potential of C2 and C8 modified quinolines: in vitro and in silico study","volume":"15","author":"Kumar","year":"2018","journal-title":"Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0115","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1021\/acs.jctc.7b00719","article-title":"Efficient geometry minimization and transition structure optimization using interpolated potential energy surfaces and iteratively updated hessians","volume":"13","author":"Zheng","year":"2017","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0120","series-title":"Dassault Systemes BIOVIA, Discovery Studio Modelling Environment, Release 4.5","first-page":"98","author":"Studio","year":"2015"},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0125","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/jcc.21287","article-title":"CHARMM: the biomolecular simulation program","volume":"30","author":"Brooks","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"Gromacs: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0135","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1107\/S0907444904011679","article-title":"PRODRG: a tool for high-throughput crystallography of protein-ligand complexes","volume":"60","author":"Sch\u00fcttelkopf","year":"2004","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0140","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0145","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0150","series-title":"Center for Coastal and Land-Margin Research","author":"Turner","year":"2005"},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0155","series-title":"Steered Molecular Dynamics","first-page":"39","author":"Izrailev","year":"1999"},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0160","first-page":"1","article-title":"Hereditary transthyretin amyloidosis overview","author":"Manganelli","year":"2020","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0165","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/07391102.2020.1711809","article-title":"Identification of a novel binding mechanism of quinoline based molecules with lactate dehydrogenase of Plasmodium falciparum","volume":"39","author":"Singh","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0170","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/jcb.30265","article-title":"A lesson for the maestro of the replication fork: targeting the protein-binding interface of proliferating cell nuclear antigen for anticancer therapy","volume":"123","author":"Bhardwaj","year":"2022","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijbiomac.2022.03.021","article-title":"Mechanistic behavior and subtle key events during DNA clamp opening and closing in T4 bacteriophage","volume":"208","author":"Bhardwaj","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0180","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1080\/07391102.2020.1772109","article-title":"Targeting the protein-protein interface pocket of Aurora-A-TPX2 complex: rational drug design and validation","volume":"39","author":"Bhardwaj","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.3709","article-title":"Computational targeting of allosteric site of MEK1 by quinoline-based molecules","author":"Singh","year":"2022","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0190","article-title":"Identification of potential mutational hotspots in serratiopeptidase to address its poor pH tolerance issue","author":"Dhiman","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0195","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.1038\/s41598-021-86211-4","article-title":"In silico studies reveal structural deviations of mutant profilin-1 and interaction with riluzole and edaravone in amyotrophic lateral sclerosis","volume":"11","author":"Sadr","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0200","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.ijbiomac.2020.01.212","article-title":"A new insight into protein-protein interactions and the effect of conformational alterations in PCNA","volume":"148","author":"Bhardwaj","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0205","doi-asserted-by":"crossref","first-page":"10037","DOI":"10.1073\/pnas.181342398","article-title":"Electrostatics of nanosystems: application to microtubules and the ribosome","volume":"98","author":"Baker","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0210","first-page":"1","article-title":"Computational insights into binding mechanism of drugs as potential inhibitors against SARS-CoV-2 targets","volume":"1","author":"Arooj","year":"2021","journal-title":"Chem. Pap."},{"key":"10.1016\/j.ijbiomac.2023.123318_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25040823","article-title":"Virtual screening approach to identify high-affinity inhibitors of serum and glucocorticoid-regulated kinase 1 among bioactive natural products: combined molecular docking and simulation studies","volume":"25","author":"Mohammad","year":"2020","journal-title":"Molecules"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023002003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023002003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:00:00Z","timestamp":1758880800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023002003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":43,"alternative-id":["S0141813023002003"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.123318","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure restoration and aggregate inhibition of V30M mutant transthyretin protein by potential quinoline molecules","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.123318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123318"}}